Dual Incretin Agonist 30mg — Verification Report

From Phase One Labz · Lot P1-30TZ06 · Tested August 2026

← Back to Phase One Labz

VialTalk

Verification report

Dual Incretin Agonist 30mg

Phase One Labz

Score

90.5

Grade

Excellent

Cap color: Unresolved(not recorded; the report and the submitter did not confirm it)

Lot P1-30TZ06

Tested August 2026

Report ID

66903e51

Test

Method

Result

Status

PurityFull credit

HPLC

99.72%

Full credit

IdentityStrong

HPLC retention time

Consistent

Strong

ContentFull credit

Gravimetric vs label claim · tested weight disclosed and verified

30 mg labeled · 31.73 mg tested

Full credit

EndotoxinNot submitted

Not tested

Not submitted

Heavy metalsNot submitted

Not tested

Not submitted

SterilityNot submitted

Not tested

Not submitted

Batch conformityNot submitted

Not tested

Not submitted

Additional screens, not scoredFentanyl screen

Verified against the submitted certificate. VialTalk received this vendor's certificate, checked each test against the reported method, and scored it under a published methodology. Tests the vendor did not submit are listed above rather than omitted.

This report is issued by VialTalk. It is not a laboratory certificate.Scoring methodology →